Related Experiment Video
Updated: Jul 3, 2025

07:49
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
167
Advancements and current trends in tumor treating fields: a scientometric analysis
Yang Xing1, Feroza Yasinjan1, Jiayue Cui2
1Department of Neurosurgery, The First Hospital of Jilin University.
International Journal of Surgery (London, England)
|February 13, 2024
Summary
Tumor Treating Fields (TTFields) therapy is a noninvasive cancer treatment showing increasing research interest. Scientometric analysis reveals TTFields research focuses on clinical applications and antitumor mechanisms, primarily for glioblastoma.
Area of Science:
- Oncology
- Biophysics
- Medical Technology
Background:
- Tumor Treating Fields (TTFields) therapy is an approved, noninvasive cancer treatment for glioblastoma and malignant pleural mesothelioma.
- TTFields therapy has garnered significant research attention due to its demonstrated efficacy.
- The field is characterized by ongoing clinical trials and preclinical studies.
Purpose of the Study:
- To conduct a scientometric analysis of TTFields research.
- To identify publication trends, leading countries/institutions, and key research areas.
- To map the current research landscape and emerging hot topics in TTFields therapy.
Main Methods:
- Scientometric analysis of publication data.
- Analysis of publication and citation trends over time.
- Mapping of countries, institutions, authors, journals, and references.
- Keyword analysis to identify research themes.
Main Results:
- Publication numbers remain high and stable, with a significant increase in citations.
- The United States and Israel lead in publications, followed by Germany and Switzerland.
- Research primarily focuses on clinical applications and antitumor mechanisms.
- Glioblastoma is the main focus of clinical trials, with other cancers also under investigation.
Conclusions:
- TTFields therapy is a rapidly growing research area with increasing global impact.
- Current research is bifurcated between clinical applications and understanding underlying antitumor mechanisms.
- Future research directions likely include expanding TTFields applications to other cancer types beyond glioblastoma.
Related Concept Videos
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

